ICTS Community Advisory Board co-chair featured in People Magazine regarding rare disease journey
Doug Lindsay describes the battle with his own rare disease. Now, he advocates for others. With over a decade spent trying to understand the rare disease that kept him bedridden for most of his 20s, Doug Lindsay learned to become his own advocate. For years he dedicated himself to investigating his symptoms and seeking help […]
Update on the Rural Health Research Center
The following update is provided by William Fay, MD, ICTS Governing Council member, Senior Associate Dean for Research at the University of Missouri School of Medicine. There are significant disparities in the health and care of rural inhabitants (who comprise about 20% of US residents) compared to the general population, particularly in vulnerable subgroups, such […]
What makes an mRNA vaccine so effective against severe COVID-19? (Links to an external site)
Shots trigger exceptional antibody response by activating key helper immune cells
Antipsychotic drugs may increase risk of breast cancer (Links to an external site)
Study focuses on role of the hormone prolactin
Washington University Team Wins Inaugural TL1 Debate, ‘Statin Wars’
Congratulations to Washington University TL1 trainees, Ameen Awad, Samuel Cortez, MD, Annahita Fotouhi, and Alexandra Zdonczyk for winning the inaugural TL1 Debate on November 9, 2021, defeating a team from the University of Michigan. The debate, a new event developed from an existing training exercise for TL1 trainees at Washington University in St. Louis, featured […]
Committing to Care, Access, Equity and Research: NORD Announces 31 Rare Disease Centers of Excellence (Links to an external site)
The National Organization for Rare Disorders (NORD) announced 31 NORD Rare Disease Centers of Excellence across the United States, establishing a unique network of medical centers, clinics, and institutions to advance care and expand access for rare disease patients.